Who
In numbers
- Trades disclosed
- 27
- Buys
- 4
- Sells
- 7
- Bought
- $26.6M
- Sold
- $2.1M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 24 Apr 2018
- Last trade
- 17 Feb 2026
- Last filed
- 19 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Feb 2026filed 19 Feb 2026 | EOLS EvolusBiotechnology | SEC FORM 4 Code A | —45,559 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | EOLS EvolusBiotechnology | SEC FORM 4 Code A | —45,559 at $0.00 | filing |
| 7 Mar 2025filed 11 Mar 2025 | EOLS Evolusoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,146 at $0.00 | filing |
| 7 Mar 2025filed 11 Mar 2025 | EOLS EvolusBiotechnology | SEC FORM 4 Code A | —7,364 at $0.00 | filing |
| 3 Jun 2024filed 5 Jun 2024 | EOLS EvolusBiotechnology | SEC FORM 4 Sold | $97K7,500 at $12.96 | filing |
| 13 May 2024filed 15 May 2024 | EOLS EvolusBiotechnology | SEC FORM 4 Sold | $362K28,000 at $12.93 | filing |
| 7 Feb 2024filed 9 Feb 2024 | EOLS Evolusoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,377 at $0.00 | filing |
| 7 Feb 2024filed 9 Feb 2024 | EOLS EvolusBiotechnology | SEC FORM 4 Code A | —6,464 at $0.00 | filing |
| 15 Aug 2023filed 15 Aug 2023 | EOLS EvolusBiotechnology | SEC FORM 4 Bought | $1.3M174,967 at $7.41 | filing |
| 11 Aug 2023filed 15 Aug 2023 | EOLS EvolusBiotechnology | SEC FORM 4 Code J | —22,998 at $0.00 | filing |
| 27 Jan 2023filed 31 Jan 2023 | EOLS Evolusoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,789 at $0.00 | filing |
| 27 Jan 2023filed 31 Jan 2023 | EOLS EvolusBiotechnology | SEC FORM 4 Code A | —8,293 at $0.00 | filing |
| 24 Jan 2022filed 26 Jan 2022 | EOLS Evolusoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,727 at $0.00 | filing |
| 24 Jan 2022filed 26 Jan 2022 | EOLS EvolusBiotechnology | SEC FORM 4 Code A | —15,568 at $0.00 | filing |
| 23 Aug 2021filed 25 Aug 2021 | EOLS EvolusBiotechnology | SEC FORM 4 Sold | $287K26,077 at $11.00 | filing |
| 20 Aug 2021filed 20 Aug 2021 | EOLS EvolusBiotechnology | SEC FORM 4 Sold | $529K49,878 at $10.61 | filing |
| 19 Aug 2021filed 20 Aug 2021 | EOLS EvolusBiotechnology | SEC FORM 4 Sold | $126K11,962 at $10.50 | filing |
| 18 Aug 2021filed 19 Aug 2021 | EOLS EvolusBiotechnology | SEC FORM 4 Sold | $261K25,000 at $10.44 | filing |
| 17 Aug 2021filed 19 Aug 2021 | EOLS EvolusBiotechnology | SEC FORM 4 Sold | $423K42,083 at $10.06 | filing |
| 26 Mar 2021filed 26 Mar 2021 | EOLS EvolusBiotechnology | SEC FORM 4 Code A | —18,011 at $0.00 | filing |
News
Lifecore Biomedical (NASDAQ:LFCR) vs. Evolus (NASDAQ:EOLS) Head to Head ComparisonEOLS · themarketsdaily.com · 14 Oct 2026Evolus (NASDAQ:EOLS) & Talphera (NASDAQ:TLPH) Financial ComparisonEOLS · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Vikram Malik; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.